Related Experiment Video
Updated: Dec 25, 2025

Detection of Invasive Pulmonary Aspergillosis in Haematological Malignancy Patients by using Lateral-flow Technology
Published on: March 22, 2012
[Leukemic pulmonary infiltration diagnosed by sputum Giemsa-staining]
Masahide Osaki1, Yoonha Lee1, Yoko Osamura2
1Department of Hematology, Japanese Red Cross Nagoya First Hospital.
This case study highlights pulmonary leukemic infiltration (PLI) in an acute myeloid leukemia (AML) patient post-transplant. Sputum Giemsa stain proved effective for rapid PLI diagnosis, aiding in clinical decision-making.
Area of Science:
- Hematology
- Oncology
- Pulmonology
Background:
- Allogeneic bone marrow transplantation is a treatment for acute myeloid leukemia (AML).
- Patients may experience complications such as relapse and infections post-transplantation.
- Pulmonary leukemic infiltration (PLI) is a rare but serious complication.
Observation:
- A 54-year-old man with AML developed pneumonia and leukemic relapse post-transplant.
- Chest CT revealed pneumonia, raising suspicion for PLI.
- Giemsa-stained sputum revealed blast cells, and FISH confirmed monosomy 7, consistent with PLI.
Findings:
- The patient's AML progressed despite treatment, leading to death.
- Autopsy confirmed diffuse alveolar damage and pathological evidence of PLI.
- Sputum Giemsa staining provided a rapid, non-invasive method for diagnosing PLI.
Implications:
- Sputum Giemsa stain can be a valuable tool for the early diagnosis of PLI.
- Prompt diagnosis of PLI may allow for timely intervention and potentially improve patient outcomes.
- This case underscores the importance of considering PLI in transplant patients presenting with respiratory symptoms and leukemic relapse.
More Related Videos
09:01Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up
Published on: March 26, 2018
03:22Author Spotlight: Advancing Pathogen Detection and Disease Assessment in Real-Time Using M-ROSE
Published on: March 1, 2024